efavirenz and Stroke

efavirenz has been researched along with Stroke in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nordling, L1
Bertrand, L; Dygert, L; Toborek, M1

Other Studies

2 other study(ies) available for efavirenz and Stroke

ArticleYear
How the genomics revolution could finally help Africa.
    Nature, 2017, 04-05, Volume: 544, Issue:7648

    Topics: Africa; Alkynes; Anti-HIV Agents; Apolipoprotein L1; Apolipoproteins; Benzoxazines; Black People; Charities; Cyclopropanes; Diabetes Mellitus, Type 2; Genetic Predisposition to Disease; Genetics, Medical; Genome-Wide Association Study; Genomics; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Kidney Diseases; Lipoproteins, HDL; National Institutes of Health (U.S.); Neoplasms; Oxazines; Piperazines; Polymorphism, Single Nucleotide; Precision Medicine; Public Health; Pyridones; Reverse Transcriptase Inhibitors; Stroke; Trypanosomiasis, African; United States; White People

2017
Antiretroviral Treatment with Efavirenz Disrupts the Blood-Brain Barrier Integrity and Increases Stroke Severity.
    Scientific reports, 2016, 12-23, Volume: 6

    Topics: Alkynes; Animals; Benzoxazines; Blood-Brain Barrier; Cell Line; Cyclopropanes; HIV Infections; Humans; Male; Mice; Severity of Illness Index; Stroke

2016